Abstract
Atrial fibrillation (AF) is the most common sustained rhythm disturbance, increasing prevalence with age, in particular in patients with cardiovascular disease. On the other hand, a subset of patients with AF being <60 years old and no evidence of underlying cardiovascular disease, and laboratory tests including thyroid function, echocardiography and exercise” test is well described. This is the called lone AF, where there is no previous cardiovascular disease, and the etiology is unknown. However, in the last years, some new factors have been related to play a role or be associated to incident AF. Conditions such as obesity, sleep apnea, alcohol intake, exercise practice, or genetic factors are associated with the development of this common arrhythmia and make the exclusion diagnosis of lone AF more complicated. The aim of the present manuscript is to provide an overview of these new risk factors for AF, which are becoming of special interest in the study of this common arrhythmia.
Keywords: Atrial fibrillation, obesity, obstructive sleep apnoea, diagnosis.
Current Pharmaceutical Design
Title:Lone Atrial Fibrillation- A Diagnosis of Exclusion
Volume: 21 Issue: 5
Author(s): Antonio Tello-Montoliu, Diana Hernández-Romero, Marianela Sanchez-Martínez, Mariano Valdes and Francisco Marín
Affiliation:
Keywords: Atrial fibrillation, obesity, obstructive sleep apnoea, diagnosis.
Abstract: Atrial fibrillation (AF) is the most common sustained rhythm disturbance, increasing prevalence with age, in particular in patients with cardiovascular disease. On the other hand, a subset of patients with AF being <60 years old and no evidence of underlying cardiovascular disease, and laboratory tests including thyroid function, echocardiography and exercise” test is well described. This is the called lone AF, where there is no previous cardiovascular disease, and the etiology is unknown. However, in the last years, some new factors have been related to play a role or be associated to incident AF. Conditions such as obesity, sleep apnea, alcohol intake, exercise practice, or genetic factors are associated with the development of this common arrhythmia and make the exclusion diagnosis of lone AF more complicated. The aim of the present manuscript is to provide an overview of these new risk factors for AF, which are becoming of special interest in the study of this common arrhythmia.
Export Options
About this article
Cite this article as:
Tello-Montoliu Antonio, Hernández-Romero Diana, Sanchez-Martínez Marianela, Valdes Mariano and Marín Francisco, Lone Atrial Fibrillation- A Diagnosis of Exclusion, Current Pharmaceutical Design 2015; 21 (5) . https://dx.doi.org/10.2174/1381612820666140825142206
DOI https://dx.doi.org/10.2174/1381612820666140825142206 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Propionate: Hypophagic Effects Observed in Animal Models Might be Transposed to the Human Obesity Management
Current Nutrition & Food Science Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists
Recent Patents on Cardiovascular Drug Discovery On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design Cardiovascular Disease Risk and Hormone Replacement Therapy (HRT): A Review Based on Randomised, Controlled Studies in Postmenopausal Women
Current Medicinal Chemistry Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?
Endocrine, Metabolic & Immune Disorders - Drug Targets Association between Fragmentation and Various Substitution Features: A Study on Isoflavonoids Analogues by CID and HCD Using LTQ Orbitrap Mass Spectrometry
Current Traditional Medicine Notch Signaling in Cardiovascular Disease and Calcification
Current Cardiology Reviews Green Tea from the Far East to the Drug Store: Focus on the Beneficial Cardiovascular Effects
Current Pharmaceutical Design 3D Printing in Modern Cardiology
Current Pharmaceutical Design Targeting Drugs to APJ Receptor: The Prospect of Treatment of Hypertension and Other Cardiovascular Diseases
Current Drug Targets Advances in the Chemistry of Saccharins: From Synthetic Novelties Towards Biologically Active Compounds
Current Medicinal Chemistry Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease
Current Pharmaceutical Design Therapeutic Approaches for the Management of Sleep Disorders in Geriatric Population
Current Medicinal Chemistry Adequacy of Quality Assurance Programs for a Corn Meal Production Unit
The Natural Products Journal Clinical Management of Diabetes Mellitus in the Older Adult Patient
Current Diabetes Reviews Dyslipidemia, Metabolic Syndrome and Vascular Disease Among Asian Indians
Vascular Disease Prevention (Discontinued) Inflammation in Ischemic Stroke Subtypes
Current Pharmaceutical Design Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands
Current Cardiology Reviews Flavonoid Rich Fraction of Dioscorea bulbifera Linn. (Yam) Enhances Mitochondrial Enzymes and Antioxidant Status, Thereby Protects Heart from Isoproterenol Induced Myocardial Infarction
Current Pharmaceutical Biotechnology Interplay Between ACE2 and Angiotensin-(1-7) in the Regulation of Blood Pressure
Current Hypertension Reviews